pxlence

pxlence is a Ghent University spin-off established in 2015 that specializes in the development and manufacturing of PCR-based assays and kits for targeted resequencing and nucleic acid quantification. The company offers three core product lines: a catalogue of nearly one million predesigned PCR assays for targeted resequencing of human exonic regions; universal Rainbow DNA detection probes designed for digital PCR and quantitative PCR to streamline multiplexing; and Human Sample ID kits used for DNA authentication and sample tracking. Their technology centers on a proprietary high-throughput primer design pipeline that allows for high-performance amplification and precise genetic targeting across various sample types, including genomic DNA, FFPE, and cfDNA.

These solutions are primarily utilized by clinical diagnostic laboratories and medical device companies to address critical needs in molecular diagnostics and precision medicine. By providing standardized, high-quality assays that integrate with NGS workflows and digital PCR platforms, pxlence helps researchers and diagnostic professionals improve accuracy, reduce costs, and simplify experimental design. The company has demonstrated the efficacy of its tools through peer-reviewed research and collaborative projects aimed at advancing cancer detection and genetic variant analysis, supporting the broader healthcare industry in enhancing diagnostic reliability and throughput.